94 related articles for article (PubMed ID: 10221180)
1. [Clinical effects of combination therapy with cefozopran and tobramycin for severe infections in patients with hematologic diseases].
Toyama K; Yaguchi M; Uchida Y; Suzuki K; Sawanobori M; Ikeda Y; Matsuoka S; Wakasugi K; Furuya T; Oshimi K; Kawamata N; Kikuchi M; Murakami H; Tsuruoka N; Tomoyasu S; Kawaguchi M; Hirosawa S; Yamamoto K; Shirota T; Harada Y; Dan K; Yamada T; Kawano K; Onozawa Y; Takeuchi J
Jpn J Antibiot; 1999 Feb; 52(2):153-61. PubMed ID: 10221180
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
Yamane T; Tanaka K; Hasuike T; Hirai M; Misu K; Ota K; Ohira H; Nakao Y; Yasui Y; Inoue T
Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Urabe A; Fujita A; Aoki K; Koike M; Kitamura K; Ohbayashi Y; Oshimi K; Wakabayashi Y; Kuraishi Y; Kurihara I; Togawa A; Hoshino S; Ozawa K; Hotta T; Higashihara M; Nagoshi H; Hirai H; Omine M; Asano S; Nishimura M; Suzuki K; Bessho M; Mizoguchi H; Furusawa S; Nonaka Y; Takaku F
Jpn J Antibiot; 2000 Feb; 53(2):61-74. PubMed ID: 10786314
[TBL] [Abstract][Full Text] [Related]
5. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
Fukuda M; Endo K; Takinami S; Kawai N; Tominaga K; Maesaki S; Bessho M; Yamazaki T
Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
[TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
7. [Optimum dose study of cefozopran in the pediatric field].
Fujii R; Sunakawa K; Sato Y; Yokota T; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Niinou K; Toyonaga Y; Ishihara T; Iwai N; Nakamura H; Kuno K; Miyajima Y; Sakurai M; Itoh M; Kawasaki H; Suga S; Kamiya H; Fujiwara T; Inui T; Taniguchi K; Nakayama M
Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluations of tobramycin in treatment of chronic complicated urinary tract infections by intravenous drip infusion administration (author's transl)].
Suzuki K
Jpn J Antibiot; 1982 Feb; 35(2):409-20. PubMed ID: 7087177
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of cefozopran as treatment for febrile neutropenia].
Saito T; Hara M; Shinagawa K; Nawa Y; Nakase K; Takeuchi M; Miyata A; Fukuda S; Sunami K; Imajoh K; Yano T; Kojima K; Teshima T; Fujii N; Ishimaru F; Ikeda K; Harada M; Tanimoto M
Gan To Kagaku Ryoho; 2004 Jan; 31(1):61-5. PubMed ID: 14750323
[TBL] [Abstract][Full Text] [Related]
10. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of severe infections and septicemia caused by S. aureus (author's transl)].
Coppens L
Rev Med Brux; 1982 Jun; 3(6):403-8. PubMed ID: 6921830
[No Abstract] [Full Text] [Related]
13. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
Sawae Y; Niho Y; Harada M; Shibuya T; Okamura T; Asano Y; Taniguchi S; Murakawa M; Toyoshima T; Kozuru M
Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
[TBL] [Abstract][Full Text] [Related]
14. [An evaluation of a therapy with antibacterial and antifungal agents infections with hematological disorders].
Inoue N; Takemoto Y; Kanamaru A; Kakishita E; Nakayama S; Hara H; Tsutsui T; Murakami R; Yamaguchi N; Tago H
Jpn J Antibiot; 1993 Jun; 46(6):486-91. PubMed ID: 8360984
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
Sukoh M; Inoue T; Morita Y; Ito K; Togano Y; Yamanaka K; Hirose S; Takahashi T; Mita S; Mano K
Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effects of micronomicin against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
Hasegawa H; Horiuchi A; Nagai K; Kanamaru A; Masaoka T; Shibata H; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y
Jpn J Antibiot; 1985 Aug; 38(8):2129-38. PubMed ID: 3908733
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
Toyama K; Torii Y; Aoki I; Kikuchi M; Wakasugi K
Jpn J Antibiot; 1992 Aug; 45(8):1003-8. PubMed ID: 1433888
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on tobramycin using intravenous drip infusion (author's transl)].
Saito A; Kikuiri T; Tomizawa M; Ujiie A; Kinoshita Y
Jpn J Antibiot; 1981 Sep; 34(9):1255-62. PubMed ID: 7328750
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of cefbuperazone in severe infections complicating hematologic diseases Hanshin Infection Study Group].
Kageyama T; Ohyabu H; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Yonezawa T
Jpn J Antibiot; 1988 Mar; 41(3):312-21. PubMed ID: 3043032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
